Dear all, The MepAnti project aims to tackle the antimicrobial resistance problem by targeting enzymes of the methylerythritol phosphate pathway. The MepAnti consortium consists of nine academic partners and seven non-academic partners coordinated by The Helmholtz Institute for Pharmaceutical Research. The consortium aims to go beyond the state-of-the-art in the anti-infective field by tackling the attractive and underexplored enzymes from the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
We have a few PhD positions in early-stage drug discovery that I would appreciate if you could bring to the attention of any interested parties. There are specifically 3 opportunities for structural biologists within the ITN: http://mepanti.hips-wordpress.helmholtz-hzi.de/ Interested parties can contact me for further information informally, but the official route for applications can be found on: https://academicpositions.com/ad/helmholtz-institute-for-pharmaceutical-research-saarland-hips/2020/12-phd-positions-early-stage-researchers-esrs-at-mepanti-consortium/145377 Thanks in advance, Matthew ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
